Deprecated: Creation of dynamic property PL_VBP_License::$version is deprecated in /var/www/healingmaps.imarkdev.com/wp-content/plugins/video-background-pro/license-page.php on line 92

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the listeo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170

Deprecated: Creation of dynamic property Vidbg_WPBakery::$vc_row_atts is deprecated in /var/www/healingmaps.imarkdev.com/wp-content/plugins/video-background-pro/inc/classes/vidbg_wpbakery.php on line 49
ketamine treatment - Page 2 of 26 - HealingMaps

4 Best Ketamine Clinics in Tacoma, WA (2026) — Verified & Reviewed

Most of Tacoma’s ketamine infrastructure sits on a single street: the region’s most experienced infusion practice and its widest-menu interventional psychiatry clinic both operate on South Union Avenue, four blocks apart. The four providers ranked here hold verified listings in the HealingMaps Washington directory, and that per-clinic detail drives the rankings; the pricing context around […]

Read More

4 Best Ketamine Clinics in Provo (2026) — Verified & Reviewed

A ketamine patient in Provo is choosing among three care models more than among neighborhoods: a national interventional psychiatry office downtown, homegrown Utah County programs built around ketamine-assisted psychotherapy, and a flat-rate infusion clinic thirty minutes up I-15. Every provider ranked below is documented in a verified HealingMaps directory listing, while the surrounding cost context […]

Read More

IV Ketamine Could Get Its First FDA Psychiatric Indication. Here Is What Would Actually Change

Last reviewed and updated: August 13, 2026. Headlines about the FDA and ketamine will multiply this year. Most operators will read them wrong. Some describe a generic manufacturing application. One concerns NRX-100, a specific IV ketamine product pursuing a psychiatric indication. That program could change how clinics approach coverage, marketing and protocols. Knowing which is […]

Read More

England Has a Recreational Ketamine Crisis. Here Is How American Clinics Keep It From Happening Here

In one Manchester treatment cohort, 64 percent of the people being treated for ketamine problems were under 18. Forty two percent were between 13 and 16. That is what a recreational ketamine crisis looks like once it has fully arrived, and England is living in one. America is not, and the reason has less to […]

Read More

Ketamine Raised Morning Cortisol in a New Trial. Here Is What That Might Mean

A randomized trial found higher morning cortisol 24 hours after ketamine. Bigger rises tracked with less suicidal thinking, though more data needed.

Read More

Before a Buyer Calls: Getting Your Ketamine Clinic Ready for Acquisition

The first call rarely announces itself as an offer. It sounds like a compliment, someone building a platform in your region admires what you have built and wonders whether you have ever thought about partners. What happens next depends almost entirely on work you either did or did not do during the two years before […]

Read More

Review Finds Evidence for Ketamine Assisted Psychotherapy Remains Limited

Ketamine clinics often pair medication with therapy, preparation, or integration. A new review asks whether psychotherapy adds measurable benefit for adults with depression. The answer remains uncertain. Researchers found widespread clinical use, but far less rigorous evidence than the popularity of these programs may suggest. New: Interested in Being Part of a Psychedelics-Focused Clinical Trial? Sign […]

Read More

The First Ketamine Clinic Roll Ups Failed. The Next Wave Will Be Different

On July 16, Eli Lilly agreed to pay up to $3.8 billion for AtaiBeckley and its late stage psychedelic depression program. A week earlier, Johnson & Johnson reported $584 million in quarterly Spravato sales, up 40 percent in a year. AbbVie has already committed up to $1.2 billion for a psychedelic depression drug from Gilgamesh. […]

Read More

What a Ketamine Infusion Costs in 2026: Every Posted Price in Our Directory, Analyzed

The national median price of a ketamine infusion in 2026 is $400. That number comes from our own directory. We reviewed all 1,793 ketamine clinic listings on HealingMaps in July 2026, identified every clinic that publicly posts a treatment price, and verified 91 standard per session prices across 30 states. No survey, no estimates, no […]

Read More

What a Mindbloom Affiliated Study Can and Cannot Tell Us About At-Home Ketamine Injections

A study reports symptom improvement among patients in Mindbloom’s at-home ketamine injections. However, this was not an independent test.

Read More